Kunii et al. demonstrated also that SLC22A16 is a mediator of platinum uptake in cancer cells, and down-regulation of SLC22A16 is possibly one of the mechanisms of resistance against cisplatin in lung cancer55. Here, SLC22A16 is linked to cancer.